Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 10, 2023

BUY
$118.38 - $210.04 $26,872 - $47,679
227 New
227 $0
Q4 2021

Jan 21, 2022

SELL
$225.82 - $368.51 $121,265 - $197,889
-537 Closed
0 $0
Q3 2021

Oct 12, 2021

BUY
$221.9 - $484.47 $119,160 - $260,160
537 New
537 $207,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Ewg Elevate Inc. Portfolio

Follow Ewg Elevate Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ewg Elevate Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ewg Elevate Inc. with notifications on news.